Carbon-11 and fluorine-18 chemistry devoted to molecular probes for imaging the brain with positron emission tomography

被引:11
|
作者
Dolle, Frederic [1 ]
机构
[1] CEA, Serv Hosp Frederic Joliot, I2BM, F-91406 Orsay, France
来源
关键词
PET chemistry; carbon-11; fluorine-18; radiochemistry; PET; CNS; brain; NUCLEOPHILIC F-18-FLUORINATION; LABELING CHEMISTRY; PET; VERSATILE;
D O I
10.1002/jlcr.3037
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Exploration of the living human brain in real-time and in a noninvasive way was for centuries only a dream, made, however, possible today with the remarkable development during the four last decades of powerful molecular imaging techniques, and especially positron emission tomography (PET). Molecular PET imaging relies, from a chemical point of view, on the use and preparation of a positron-emitting radiolabelled probe or radiotracer, notably compounds incorporating one of two short-lived radionuclides fluorine-18 (T1/2: 109.8min) and carbon-11 (T1/2: 20.38min). The growing availability and interest for the radiohalogen fluorine-18 in radiopharmaceutical chemistry undoubtedly results from its convenient half-life and the successful use in clinical oncology of 2-[18F]fluoro-2-deoxy-d-glucose ([18F]FDG). The special interest of carbon-11 is not only that carbon is present in virtually all biomolecules and drugs allowing therefore for isotopic labelling of their chemical structures but also that a given molecule could be radiolabelled at different functions or sites, permitting to explore (or to take advantage of) in vivo metabolic pathways. PET chemistry includes production of these short-lived radioactive isotopes via nuclear transmutation reactions using a cyclotron, and is directed towards the development of rapid synthetic methods, at the trace level, for the introduction of these nuclides into a molecule, as well as the use of fast purification, analysis and formulation techniques. PET chemistry is the driving force in molecular PET imaging, and this special issue of the Journal of Labelled Compounds and Radiopharmaceuticals, which is strongly chemistry and radiochemistry-oriented, aims at illustrating, be it in part only, the state-of-the-art arsenal of reactions currently available and its potential for the research and development of specific molecular probes labelled with the positron emitters carbon-11 and fluorine-18, with optimal imaging properties for PET exploration of the brain. Copyright (c) 2013 John Wiley & Sons, Ltd.
引用
收藏
页码:65 / 67
页数:3
相关论文
共 50 条
  • [21] Imaging of pancreatic cancer using fluorine-18 fluorodeoxyglucose positron emission tomography
    Alazraki, N
    JOURNAL OF GASTROINTESTINAL SURGERY, 2002, 6 (02) : 136 - 138
  • [22] Comparison of fluorine-18 and bromine-76 imaging in positron emission tomography
    Maria João Ribeiro
    Pedro Almeida
    Daniel Strul
    Nuno Ferreira
    Christian Loc’h
    Vincent Brulon
    Régine Trébossen
    Bernard Mazière
    Bernard Bendriem
    European Journal of Nuclear Medicine, 1999, 26 : 758 - 766
  • [23] Comparison of fluorine-18 and bromine-76 imaging in positron emission tomography
    Ribeiro, MJ
    Almeida, P
    Strul, D
    Ferreira, N
    Loc'h, C
    Brulon, V
    Trébossen, R
    Mazière, B
    Bendriem, B
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (07) : 758 - 766
  • [24] The use of fluorine-18 fluorodeoxyglucose positron emission tomography for imaging human motor neuronal activation in the brain
    Pahk, Kisoo
    Park, Kun-Woo
    Pyun, Sung Bom
    Lee, Jae Sung
    Kim, Sungeun
    Choe, Jae Gol
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 10 (06) : 2126 - 2130
  • [25] Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose
    Division of Nuclear Medicine, University Hospital, Sart Tilman, Liege, Belgium
    不详
    不详
    不详
    不详
    Eur. J. Nucl. Med. Mol. Imaging, 12 (1641-1674):
  • [26] Site-specific labeling of scVEGF with Fluorine-18 for positron emission tomography imaging
    Wang, Hui
    Gao, Haokao
    Guo, Ning
    Niu, Gang
    Ma, Ying
    Kiesewetter, Dale
    Chen, Xiaoyuan
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [27] Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation
    Michael T. Osborne
    Edward A. Hulten
    Venkatesh L. Murthy
    Hicham Skali
    Viviany R. Taqueti
    Sharmila Dorbala
    Marcelo F. DiCarli
    Ron Blankstein
    Journal of Nuclear Cardiology, 2017, 24 : 86 - 99
  • [28] Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose
    Rigo, P
    Paulus, P
    Kaschten, BJ
    Hustinx, R
    Bury, T
    Jerusalem, G
    Benoit, T
    FoidartWillems, J
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1996, 23 (12): : 1641 - 1674
  • [29] Positron emission tomography with fluorine-18 deoxyglucose in the diagnosis of spondylodiscitis
    Palmedo, H
    Schmitz, A
    Risse, J
    Reinhardt, MJ
    Krause, T
    Matthies, A
    Schmitt, O
    Biersack, HJ
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (08): : 987 - 987
  • [30] Site-Specific Labeling of scVEGF with Fluorine-18 for Positron Emission Tomography Imaging
    Wang, Hui
    Gao, Haokao
    Guo, Ning
    Niu, Gang
    Ma, Ying
    Kiesewetter, Dale O.
    Chen, Xiaoyuan
    THERANOSTICS, 2012, 2 (06): : 607 - 617